Other specified / Unspecified schizophrenia spectrum disorder
Symptoms characteristic of a schizophrenia spectrum/other psychotic disorder causing clinically significant distress/impairment
Symptoms characteristic of a schizophrenia spectrum/other psychotic disorder causing clinically significant distress/impairment
Prominent hallucinations or delusions
≥2 of: delusions; hallucinations; disorganised speech; grossly disorganised/catatonic behaviour; negative symptoms — ≥1 must be delusions, hallucinations, or disorganised speech
Persistent deficits in social communication/interaction across multiple contexts (≥3 components: social-emotional reciprocity; nonverbal communicative behaviours; developing/maintaining relationships)
Hypomanic episode threshold has been met.
≥5 of 9 SIG-E-CAPS symptoms for ≥2 weeks; ≥1 must be depressed mood or anhedonia
≥3 of 12 catatonia symptoms: stupor; catalepsy; waxy flexibility; mutism; negativism; posturing; mannerism; stereotypy; agitation; grimacing; echolalia; echopraxia
Pervasive pattern of disregard for/violation of rights of others since age 15: ≥3 of 7: failure to conform to lawful behaviours; deceitfulness; impulsivity; irritability/aggressiveness; reckless disregard for safety; consistent irresponsibility; lack of remorse
≥6 inattentive symptoms and/or ≥6 hyperactive-impulsive symptoms (≥5 for age ≥17) for ≥6 months, inconsistent with developmental level and negatively impacting activities
≥1 full manic episode (abnormally elevated/expansive/irritable mood + ↑energy, ≥7 days or any duration if hospitalised)
≥1 of: delusions; hallucinations; disorganised speech; grossly disorganised/catatonic behaviour
≥2 years (≥1 yr children/adolescents) of hypomanic AND depressive symptoms not meeting full episode criteria
≥1 month of ≥1 delusion(s)
Marked incongruence between one's experienced/expressed gender and assigned gender, ≥6 months; in adolescents/adults: ≥2 of: incongruence between experienced gender and primary/secondary sex characteristics; strong desire to be rid of primary/secondary sex characteristics; strong desire for sex characteristics of experienced gender; strong desire to be of experienced gender; strong desire to be treated as experienced gender; strong conviction of having typical feelings/reactions of experienced gender
Consistent pattern of inhibited, emotionally withdrawn behaviour toward caregivers; ≥2 of: rarely seeks/responds to comfort when distressed; minimal positive affect; unexplained irritability/sadness/fearfulness
Uninterrupted period of illness including a major mood episode (MDE or manic) concurrent with Schizophrenia Criterion A symptoms
Same symptom criteria as Schizophrenia (≥2 of the 5 symptom clusters; ≥1 must be delusions, hallucinations, or disorganised speech)
Presence of obsessions (recurrent/persistent intrusive thoughts/urges/images + attempts to suppress or neutralise), compulsions (repetitive behaviours/mental acts driven by rigid rules aimed at reducing distress/feared event), or both
Intoxication: recent stimulant use; Withdrawal: cessation/reduction after prolonged heavy use
Symptoms characteristic of a bipolar/related disorder causing clinically significant distress/impairment
Intoxication: reversible substance-specific syndrome due to recent ingestion; Withdrawal: substance-specific syndrome due to cessation/reduction after heavy/prolonged use
Prominent anxiety, panic attacks, or obsessions/compulsions directly attributable to physiological effects of another medical condition
Preoccupation with ≥1 perceived defect(s) or flaw(s) in physical appearance (not observable or only slightly observable to others)
Intoxication: recent cannabis use with clinically significant maladaptive behavioural/psychological changes; Withdrawal: cessation/reduction of heavy prolonged use
Evidence by polysomnography of ≥5 central apnoeas per hour of sleep
Prominent depressive episode directly attributable to physiological effects of a medical condition
Acquisition and execution of coordinated motor skills is substantially below expected for chronological age and opportunity for skill learning
Recurrent skin picking resulting in skin lesions
≥1 symptom of altered voluntary motor or sensory function
Persistent or recurrent difficulties with ≥1 of: vaginal penetration during intercourse; marked vulvovaginal or pelvic pain during intercourse or penetration attempts; marked fear/anxiety about vulvovaginal or pelvic pain in anticipation of, during, or as a result of vaginal penetration; marked tensing or tightening of pelvic floor muscles during vaginal penetration attempts
Failure to meet expected developmental milestones in several areas of intellectual functioning; applies to individuals <5 years when severity cannot be reliably assessed
Predominant complaint of dissatisfaction with sleep quantity/quality: ≥1 of: difficulty initiating sleep; difficulty maintaining sleep (frequent awakenings); early morning awakening with inability to return to sleep
Recurrent outbursts of failure to control aggressive impulses; ≥1 of: verbal aggression or physical aggression toward property/animals/individuals ≥2×/week (on average) for ≥3 months; ≥3 aggressive outbursts involving damage/injury within a 12-month period
Persistently or recurrently deficient (or absent) sexual/erotic thoughts or fantasies AND desire for sexual activity; clinician judges deficiency considering age and general/sociocultural context
Abnormal and prolonged contraction of muscles of eyes, face, neck, limbs, or trunk developing in association with medication use
Parkinsonian tremor, muscular rigidity, or akinesia developing in association with medication use (most commonly neuroleptic/antipsychotic or dopamine-depleting agent)
Criteria met for major or mild NCD
Evidence by polysomnography of ≥5 obstructive apnoeas/hypopnoeas per hour of sleep + ≥1 of: nocturnal breathing disturbances (snoring, snorting, gasping, breathing pauses); daytime sleepiness/fatigue/unrefreshing sleep not explained by another disorder; OR ≥15 obstructive apnoeas/hypopnoeas per hour of sleep regardless of accompanying symptoms
Intoxication: recent opioid use; Withdrawal: cessation/reduction after heavy prolonged use, or administration of opioid antagonist
Medication-induced movement symptoms causing clinically significant distress or impairment
Symptoms characteristic of a feeding/eating disorder causing clinically significant distress/impairment
Symptoms characteristic of an OCD-related disorder causing clinically significant distress/impairment
Symptoms characteristic of a sexual dysfunction causing clinically significant distress
Symptoms characteristic of a somatic symptom/related disorder causing clinically significant distress/impairment
Symptoms characteristic of a trauma/stressor-related disorder causing clinically significant distress/impairment
Symptoms characteristic of a bipolar/related disorder causing clinically significant distress/impairment
Over ≥6 months, recurrent, intense sexually arousing fantasies, urges, or behaviours involving sexual activity with a prepubescent child or children (generally ≤13 years)
Persistent personality disturbance representing a change from the individual's previous characteristic personality pattern
Persistent eating of non-nutritive, non-food substances for ≥1 month
Pervasive pattern of social/interpersonal deficits with acute discomfort in close relationships, cognitive/perceptual distortions, and eccentricities of behaviour, beginning by early adulthood; ≥5 of 9: ideas of reference; odd beliefs/magical thinking; unusual perceptual experiences; odd thinking/speech; suspiciousness/paranoid ideation; inappropriate/constricted affect; odd/eccentric behaviour/appearance; lacks close friends; excessive social anxiety
Intoxication: recent sedative/hypnotic/anxiolytic use; Withdrawal: cessation/reduction after prolonged heavy use
Persistent difficulties in social use of verbal/nonverbal communication; ≥1 of: deficits in using communication for social purposes; inability to change communication to match context; difficulty following rules for conversations and storytelling; difficulty understanding what is not explicitly stated
Prominent hallucinations or delusions
Involuntary athetoid or choreiform movements (lasting ≥4 weeks) of the tongue, jaw, trunk, or extremities that developed in association with use of a neuroleptic medication
Involuntary movements (tardive dystonia: sustained/repetitive muscle contractions; tardive akathisia: subjective restlessness + repetitive movements) developing in association with neuroleptic use, persisting ≥4 weeks